Adaptive Biotechnologies revenue rises 57% in 2021 to $154.3M
GeekWire
FEBRUARY 15, 2022
Adaptive Biotechnologies , which develops technology to assess the immune response, posted $154.3 Net loss for 2021 came in at $207.3 million in the fourth quarter, up 26%, with a net loss of $61.4 Adaptive moved into its new headquarters in September. Co-founders Harlan (left) and Chad Robins on the new plaza. million in 2020.
Let's personalize your content